Recent studies have shown that interleukin 6 (IL-6) and the major downstream effector signal transducer and activator of transcription 3 (STAT3) are pro-tumorigenic agents in a variety of human cancers, including PDAC (Taher et al. 2018). This evidence concerns the gene STAT3 and cancer.